Search by Drug Name or NDC

    NDC 00002-8213-05 Humalog 100 [iU]/mL Details

    Humalog 100 [iU]/mL

    Humalog is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is INSULIN LISPRO.

    Product Information

    NDC 00002-8213
    Product ID 0002-8213_e57e8ab9-295b-4fb7-b723-e7b008117e9a
    Associated GPIs
    GCN Sequence Number 085480
    GCN Sequence Number Description insulin lispro INSULN PEN 100/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 54975
    HICL Sequence Number 011528
    HICL Sequence Number Description INSULIN LISPRO
    Brand/Generic Brand
    Proprietary Name Humalog
    Proprietary Name Suffix Tempo Pen
    Non-Proprietary Name Insulin lispro
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN LISPRO
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Insulin Analog [EPC], Insulin [Chemical/Ingredient]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA020563
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-8213-05 (00002821305)

    NDC Package Code 0002-8213-05
    Billing NDC 00002821305
    Package 5 SYRINGE in 1 CARTON (0002-8213-05) / 3 mL in 1 SYRINGE (0002-8213-01)
    Marketing Start Date 2019-11-15
    NDC Exclude Flag N
    Pricing Information N/A